Concepedia

Alex Posch

AP

Statistics

Publications

1

Citations

21

H-Index

1

Active since

2018

Affiliations

Agilent Technologies (United States)(Current)

Alex Posch is an author at Agilent Technologies (United States) specializing in inflammatory lung disease, cancer therapeutics, and tumor immunity.

Top concepts

Publications per year

2018–2018

1

Publications

1

Investigation of PD-L1 expression and response to pembrolizumab (pembro) in gastric cancer (GC) and cervical cancer (CC) using combined positive score (CPS) and tumor proportion score (TPS).

Karina Kulangara, Lindsay Guerrero, Alex Posch et al. · Journal of Clinical Oncology · 2018 · 21 citations

, , +18

1–1 of 1